These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7736484)

  • 21. A double-blind, placebo-controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris.
    Taylor SH; Lee P; Jackson N; Cocco G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S46-9. PubMed ID: 16296709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
    Deedwania PC; Cheitlin MD; Das SK; Pool PE; Singh JB; Pasternak RC
    Clin Cardiol; 1993 Aug; 16(8):599-602. PubMed ID: 8370191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of arrhythmias in the Circadian Antiischemia Program in Europe (CAPE) study.
    Lichtlen PR; Fisher LD
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):135-9. PubMed ID: 9890408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
    Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
    Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152.
    Singh S
    Clin Cardiol; 1993 Jan; 16(1):54-8. PubMed ID: 8416762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of amlodipine for angina pectoris.
    Taylor SH
    Am J Cardiol; 1994 Jan; 73(3):28A-33A. PubMed ID: 8310973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological risk factors may moderate pharmacological treatment effects among ischemic heart disease patients. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
    Rutledge T; Linden W; Davies RF
    Psychosom Med; 1999; 61(6):834-41. PubMed ID: 10593636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open comparative study to assess the efficacy and safety of two calcium antagonists: amlodipine and diltiazem in the treatment of symptomatic myocardial ischemia.
    Canale C; Terrachini V; Masperone MA; Caponnetto S
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S57-60. PubMed ID: 16296712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
    Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
    Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).
    Andrews TC; Fenton T; Toyosaki N; Glasser SP; Young PM; MacCallum G; Gibson RS; Shook TL; Stone PH
    Circulation; 1993 Jul; 88(1):92-100. PubMed ID: 8319361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open multicenter efficacy and safety evaluation of amlodipine in the treatment of symptomatic myocardial ischemia.
    Beckerman B;
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S61-4. PubMed ID: 16296713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anipamil prevents ST depression in patients with stable angina pectoris.
    Larsen CT; Sørum C; Rasmussen V; Fischer Hansen J
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):915-21. PubMed ID: 8011571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amlodipine in patients with stable angina pectoris treated with beta-blockers. Double-blind comparison with placebo.
    Rossinen J; Partanen J; Nieminen MS
    Scand Cardiovasc J; 1998; 32(1):41-8. PubMed ID: 9536505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and additional anti-ischaemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and long-term therapy of stable angina pectoris in patients pre-treated with a beta-blocker.
    Lehmann G; Reiniger G; Beyerle A; Rudolph W
    Eur Heart J; 1993 Nov; 14(11):1531-5. PubMed ID: 7905413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.